For research use only
| Cat No. | ABC-X0197C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The human ERBB2 (S310Y) BAF3 Cell Line offers a platform for researching HER2 mutation-driven signaling and testing HER2-directed therapeutics.
Human ERBB2 (S310Y) BAF3 Cell Line is a stable Ba/F3 cell line modified to express the human ERBB2 S310Y variant. Stable expression is achieved through lentiviral vector transduction and confirmed by qRT-PCR. Cell line passage is restricted to <P20. Target The ERBB2 S310Y mutation confers constitutive activation and is linked to resistance against certain HER2 inhibitors. It activates downstream PI3K/AKT and MAPK pathways in oncogenesis. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers' research needs.
| Species | Human |
| Cat.No | ABC-X0197C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This model enables evaluation of HER2-targeted therapies, including antibody-drug conjugates and TKIs, and is applicable for dissecting mutant-specific resistance pathways.